{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:34:45Z","timestamp":1790310885013,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s13402-012-0078-4","type":"journal-article","created":{"date-parts":[[2012,4,11]],"date-time":"2012-04-11T09:29:55Z","timestamp":1334136595000},"page":"189-196","source":"Crossref","is-referenced-by-count":90,"title":["EGFR and KRAS mutations in lung carcinomas in the Dutch population: increased EGFR mutation frequency in malignant pleural effusion of lung adenocarcinoma"],"prefix":"10.1007","volume":"35","author":[{"given":"Alexander J. J.","family":"Smits","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Alain","family":"Kummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W. J.","family":"Hinrichs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerarda J. M.","family":"Herder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen C.","family":"Scheidel-Jacobse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. Mehdi","family":"Jiwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Emiel G.","family":"Ruijter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peet T. G. A.","family":"Nooijen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica G.","family":"Looijen-Salamon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolijn J. L.","family":"Ligtenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik B.","family":"Thunnissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00eblle A. M.","family":"Heideman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roel A.","family":"de Weger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aryan","family":"Vink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,4,12]]},"reference":[{"key":"78_CR1","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S1470-2045(08)70206-7","volume":"9","author":"H Linardou","year":"2008","unstructured":"H. Linardou, I.J. Dahabreh, D. Kanaloupiti, F. Siannis, D. Bafaloukos, P. Kosmidis et al., Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer. Lancet Oncol. 9, 962\u2013972 (2008)","journal-title":"Lancet Oncol."},{"key":"78_CR2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cancergencyto.2006.10.007","volume":"173","author":"NC Bae","year":"2007","unstructured":"N.C. Bae, M.H. Chae, M.H. Lee, K.M. Kim, E.B. Lee, C.H. Kim et al., EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients. Cancer Genet. Cytogenet. 173, 107\u2013113 (2007)","journal-title":"Cancer Genet. Cytogenet."},{"key":"78_CR3","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/JTO.0b013e3181e05016","volume":"5","author":"B Gao","year":"2010","unstructured":"B. Gao, Y. Sun, J. Zhang, Y. Ren, R. Fang, X. Han et al., Spectrum of LKB1, EGFR, and KRAS mutations in chinese lung adenocarcinomas. J. Thorac. Oncol. 5, 1130\u20131135 (2010)","journal-title":"J. Thorac. Oncol."},{"key":"78_CR4","doi-asserted-by":"crossref","first-page":"e426","DOI":"10.1371\/journal.pone.0000426","volume":"2","author":"JL Marks","year":"2007","unstructured":"J.L. Marks, M.D. McLellan, M.F. Zakowski, A.E. Lash, Y. Kasai, S. Broderick et al., Mutational analysis of EGFR and related signaling pathway genes in lung adenocarcinomas identifies a novel somatic kinase domain mutation in FGFR4. PLoS One 2, e426 (2007)","journal-title":"PLoS One"},{"key":"78_CR5","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1158\/1078-0432.CCR-05-1846","volume":"12","author":"GJ Riely","year":"2006","unstructured":"G.J. Riely, W. Pao, D. Pham, A.R. Li, N. Rizvi, E.S. Venkatraman et al., Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib. Clin. Cancer Res. 12, 839\u2013844 (2006)","journal-title":"Clin. Cancer Res."},{"key":"78_CR6","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1097\/JTO.0b013e3181f0beca","volume":"5","author":"SY Lee","year":"2010","unstructured":"S.Y. Lee, M.J. Kim, G. Jin, S.S. Yoo, J.Y. Park, J.E. Choi et al., Somatic mutations in epidermal growth factor receptor signaling pathway genes in non-small cell lung cancers. J. Thorac. Oncol. 5, 1734\u20131740 (2010)","journal-title":"J. Thorac. Oncol."},{"key":"78_CR7","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1136\/jcp.2009.067587","volume":"62","author":"A Fassina","year":"2009","unstructured":"A. Fassina, A. Gazziero, D. Zardo, M. Corradin, E. Aldighieri, G.P. Rossi, Detection of EGFR and KRAS mutations on trans-thoracic needle aspiration of lung nodules by high resolution melting analysis. J. Clin. Pathol. 62, 1096\u20131102 (2009)","journal-title":"J. Clin. Pathol."},{"key":"78_CR8","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.humpath.2010.01.008","volume":"41","author":"S Chiosea","year":"2010","unstructured":"S. Chiosea, Y. Shuai, K. Cieply, M.N. Nikiforova, S. Dacic, EGFR fluorescence in situ hybridization-positive lung adenocarcinoma: incidence of coexisting KRAS and BRAF mutations. Hum. Pathol. 41, 1053\u20131060 (2010)","journal-title":"Hum. Pathol."},{"key":"78_CR9","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1200\/JCO.2005.08.043","volume":"23","author":"A Marchetti","year":"2005","unstructured":"A. Marchetti, C. Martella, L. Felicioni, F. Barassi, S. Salvatore, A. Chella et al., EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment. J. Clin. Oncol. 23, 857\u2013865 (2005)","journal-title":"J. Clin. Oncol."},{"key":"78_CR10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1378\/chest.128.1.317","volume":"128","author":"RK Hsieh","year":"2005","unstructured":"R.K. Hsieh, K.H. Lim, H.T. Kuo, C.Y. Tzen, M.J. Huang, Female sex and bronchioloalveolar pathologic subtype predict EGFR mutations in non-small cell lung cancer. Chest 128, 317\u2013321 (2005)","journal-title":"Chest"},{"key":"78_CR11","first-page":"329","volume":"31","author":"DA Heideman","year":"2009","unstructured":"D.A. Heideman, F.B. Thunnissen, M. Doeleman, D. Kramer, H.M. Verheul, E.F. Smit et al., A panel of high resolution melting (HRM) technology-based assays with direct sequencing possibility for effective mutation screening of EGFR and K-ras genes. Cell. Oncol. 31, 329\u2013333 (2009)","journal-title":"Cell. Oncol."},{"key":"78_CR12","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1183\/09031936.00167407","volume":"32","author":"SG Wu","year":"2008","unstructured":"S.G. Wu, C.H. Gow, C.J. Yu, Y.L. Chang, C.H. Yang, Y.C. Hsu et al., Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma. Eur. Respir. J. 32, 924\u2013930 (2008)","journal-title":"Eur. Respir. J."},{"key":"78_CR13","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/ijc.21940","volume":"119","author":"S Matsumoto","year":"2006","unstructured":"S. Matsumoto, K. Takahashi, R. Iwakawa, Y. Matsuno, Y. Nakanishi, T. Kohno et al., Frequent EGFR mutations in brain metastases of lung adenocarcinoma. Int. J. Cancer 119, 1491\u20131494 (2006)","journal-title":"Int. J. Cancer"},{"key":"78_CR14","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/annonc\/mdn679","volume":"20","author":"CH Gow","year":"2009","unstructured":"C.H. Gow, Y.L. Chang, Y.C. Hsu, M.F. Tsai, C.T. Wu, C.J. Yu et al., Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer. Ann. Oncol. 20, 696\u2013702 (2009)","journal-title":"Ann. Oncol."},{"key":"78_CR15","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1158\/1078-0432.CCR-09-0089","volume":"15","author":"K Schmid","year":"2009","unstructured":"K. Schmid, N. Oehl, F. Wrba, R. Pirker, C. Pirker, M. Filipits, EGFR\/KRAS\/BRAF mutations in primary lung adenocarcinomas and corresponding locoregional lymph node metastases. Clin. Cancer Res. 15, 4554\u20134560 (2009)","journal-title":"Clin. Cancer Res."},{"key":"78_CR16","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJMoa0904554","volume":"361","author":"R Rosell","year":"2009","unstructured":"R. Rosell, T. Moran, C. Queralt, R. Porta, F. Cardenal, C. Camps et al., Screening for epidermal growth factor receptor mutations in lung cancer. N. Engl. J. Med. 361, 958\u2013967 (2009)","journal-title":"N. Engl. J. Med."},{"key":"78_CR17","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/JTO.0b013e31820db209","volume":"6","author":"A Helland","year":"2011","unstructured":"A. Helland, H.M. Skaug, L. Kleinberg, M.L. Iversen, A.K. Rud, T. Fleischer et al., EGFR gene alterations in a Norwegian cohort of lung cancer patients selected for surgery. J. Thorac. Oncol. 6, 947\u2013950 (2011)","journal-title":"J. Thorac. Oncol."},{"key":"78_CR18","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/jnci\/dji055","volume":"97","author":"H Shigematsu","year":"2005","unstructured":"H. Shigematsu, L. Lin, T. Takahashi, M. Nomura, M. Suzuki, I.I. Wistuba et al., Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J. Natl. Cancer Inst. 97, 339\u2013346 (2005)","journal-title":"J. Natl. Cancer Inst."},{"key":"78_CR19","first-page":"161","volume":"31","author":"D Kramer","year":"2009","unstructured":"D. Kramer, F.B. Thunnissen, M.I. Gallegos-Ruiz, E.F. Smit, P.E. Postmus, C.J. Meijer et al., A fast, sensitive and accurate high resolution melting (HRM) technology-based assay to screen for common K-ras mutations. Cell. Oncol. 31, 161\u2013167 (2009)","journal-title":"Cell. Oncol."},{"key":"78_CR20","doi-asserted-by":"crossref","unstructured":"S.A. Forbes, G. Bhamra, S. Bamford, E. Dawson, C. Kok, J. Clements et al., The Catalogue of Somatic Mutations in Cancer (COSMIC). Curr. Protoc. Hum. Genet. Chapter 10, Unit-(2008)","DOI":"10.1002\/0471142905.hg1011s57"},{"key":"78_CR21","first-page":"623","volume":"18","author":"H Sasaki","year":"2007","unstructured":"H. Sasaki, K. Okuda, O. Kawano, K. Endo, H. Yukiue, T. Yokoyama et al., Nras and Kras mutation in Japanese lung cancer patients: Genotyping analysis using LightCycler. Oncol. Rep. 18, 623\u2013628 (2007)","journal-title":"Oncol. Rep."},{"key":"78_CR22","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1002\/1097-0142(20010915)92:6<1525::AID-CNCR1478>3.0.CO;2-H","volume":"92","author":"SA Ahrendt","year":"2001","unstructured":"S.A. Ahrendt, P.A. Decker, E.A. Alawi, Y.R. Zhu Yr, M. Sanchez-Cespedes, S.C. Yang et al., Cigarette smoking is strongly associated with mutation of the K-ras gene in patients with primary adenocarcinoma of the lung. Cancer 92, 1525\u20131530 (2001)","journal-title":"Cancer"},{"key":"78_CR23","doi-asserted-by":"crossref","first-page":"7232","DOI":"10.1158\/1078-0432.CCR-06-0658","volume":"12","author":"GJ Riely","year":"2006","unstructured":"G.J. Riely, K.A. Politi, V.A. Miller, W. Pao, Update on epidermal growth factor receptor mutations in non-small cell lung cancer. Clin. Cancer Res. 12, 7232\u20137241 (2006)","journal-title":"Clin. Cancer Res."},{"key":"78_CR24","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.1200\/JCO.2005.01.0793","volume":"23","author":"T Takano","year":"2005","unstructured":"T. Takano, Y. Ohe, H. Sakamoto, K. Tsuta, Y. Matsuno, U. Tateishi et al., Epidermal growth factor receptor gene mutations and increased copy numbers predict gefitinib sensitivity in patients with recurrent non-small-cell lung cancer. J. Clin. Oncol. 23, 6829\u20136837 (2005)","journal-title":"J. Clin. Oncol."},{"key":"78_CR25","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.1200\/JCO.2009.23.1431","volume":"27","author":"RS Leidner","year":"2009","unstructured":"R.S. Leidner, P. Fu, B. Clifford, A. Hamdan, C. Jin, R. Eisenberg et al., Genetic abnormalities of the EGFR pathway in African American Patients with non-small-cell lung cancer. J. Clin. Oncol. 27, 5620\u20135626 (2009)","journal-title":"J. Clin. Oncol."},{"key":"78_CR26","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1158\/1078-0432.CCR-07-1468","volume":"14","author":"CH Gow","year":"2008","unstructured":"C.H. Gow, C.R. Chien, Y.L. Chang, Y.H. Chiu, S.H. Kuo, J.Y. Shih et al., Radiotherapy in lung adenocarcinoma with brain metastases: effects of activating epidermal growth factor receptor mutations on clinical response. Clin. Cancer Res. 14, 162\u2013168 (2008)","journal-title":"Clin. Cancer Res."},{"key":"78_CR27","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1200\/JCO.2007.15.6695","volume":"26","author":"CH Yang","year":"2008","unstructured":"C.H. Yang, C.J. Yu, J.Y. Shih, Y.C. Chang, F.C. Hu, M.C. Tsai et al., Specific EGFR mutations predict treatment outcome of stage IIIB\/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy. J. Clin. Oncol. 26, 2745\u20132753 (2008)","journal-title":"J. Clin. Oncol."},{"key":"78_CR28","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3346\/jkms.2007.22.3.393","volume":"22","author":"II Na","year":"2007","unstructured":"I.I. Na, J.K. Rho, Y.J. Choi, C.H. Kim, J.S. Koh, B.Y. Ryoo et al., Clinical features reflect exon sites of EGFR mutations in patients with resected non-small-cell lung cancer. J. Korean Med. Sci. 22, 393\u2013399 (2007)","journal-title":"J. Korean Med. Sci."},{"key":"78_CR29","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000112947","volume":"72","author":"J Okami","year":"2007","unstructured":"J. Okami, K. Taniguchi, M. Higashiyama, J. Maeda, K. Oda, N. Orita et al., Prognostic factors for gefitinib-treated postoperative recurrence in non-small cell lung cancer. Oncology 72, 234\u2013242 (2007)","journal-title":"Oncology"},{"key":"78_CR30","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1056\/NEJMoa044238","volume":"352","author":"S Kobayashi","year":"2005","unstructured":"S. Kobayashi, T.J. Boggon, T. Dayaram, P.A. Janne, O. Kocher, M. Meyerson et al., EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. N. Engl. J. Med. 352, 786\u2013792 (2005)","journal-title":"N. Engl. J. Med."},{"key":"78_CR31","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1056\/NEJM200505193522019","volume":"352","author":"S Toyooka","year":"2005","unstructured":"S. Toyooka, K. Kiura, T. Mitsudomi, EGFR mutation and response of lung cancer to gefitinib. N. Engl. J. Med. 352, 2136 (2005)","journal-title":"N. Engl. J. Med."},{"key":"78_CR32","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.1158\/1078-0432.CCR-07-5123","volume":"14","author":"JY Wu","year":"2008","unstructured":"J.Y. Wu, S.G. Wu, C.H. Yang, C.H. Gow, Y.L. Chang, C.J. Yu et al., Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response. Clin. Cancer Res. 14, 4877\u20134882 (2008)","journal-title":"Clin. Cancer Res."},{"key":"78_CR33","doi-asserted-by":"crossref","first-page":"5900","DOI":"10.1200\/JCO.2005.02.857","volume":"23","author":"DA Eberhard","year":"2005","unstructured":"D.A. Eberhard, B.E. Johnson, L.C. Amler, A.D. Goddard, S.L. Heldens, R.S. Herbst et al., Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib. J. Clin. Oncol. 23, 5900\u20135909 (2005)","journal-title":"J. Clin. Oncol."}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-012-0078-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T04:24:44Z","timestamp":1561609484000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13402-012-0078-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,12]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["78"],"URL":"https:\/\/doi.org\/10.1007\/s13402-012-0078-4","relation":{},"ISSN":["2211-3428","2211-3436"],"issn-type":[{"value":"2211-3428","type":"print"},{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,12]]}}}